Pharmacokinetic Analysis of Hypoxia 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer
Authors:
Open Access
- 15 December 2009
- journal article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 51 (1) , 37-45
Abstract
This study used pharmacokinetic analysis of 18F-labeled fluoromisonidazole (18F-FMISO) dynamic PET to assist the identification of regional tumor hypoxia and to investigate the relationship among a potential tumor hypoxia index (Ki), tumor-to-blood ratio (T/B) in the late-time image, plasma-to-tissue transport rate (k1), and local vascular volume fraction (β) for head and neck cancer patients. Methods: Newly diagnosed patients underwent a dynamic 18F-FMISO PET scan before chemotherapy or radiotherapy. The data were acquired in 3 consecutive PET/CT dynamic scan segments, registered with each other and analyzed using pharmacokinetics software. The (Ki, k1, β) kinetic parameter images were derived for each patient. Results: Nine patients' data were analyzed. Representative images of 18F-FDG PET (of the tumor), CT (of the anatomy), and late-time 18F-FMISO PET (of the T/B) and parametric images of Ki (potentially representing tumor hypoxia) are shown. The patient image data could be classified into 3 types: with good concordance between the parametric hypoxia map Ki and high T/B, with concordant findings between the parametric hypoxia map and low T/B, and with ambiguity between parametric hypoxia map and T/B. Correlation coefficients are computed between each pair of T/B, Ki, k1, and β. Data are also presented for other potential hypoxia surrogate measures, for example, k3 and k1/k2. Conclusion: There is a positive correlation of 0.86 between the average T/B and average hypoxia index Ki of the region of interest. However, because of the statistical photon counting noise in PET and the amplification of noise in kinetic analysis, the direct correlation between the T/B and hypoxia of the individual pixel is not obvious. For a tumor region of interest, there is a slight negative correlation between k1 and Ki, moderate positive correlation between β and Ki, but no correlation between β and k1.Keywords
This publication has 23 references indexed in Scilit:
- Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imagingPhysics in Medicine & Biology, 2009
- pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?BMC Cancer, 2007
- Hypoxia-imaging with 18F-Misonidazole and PET: Changes of kinetics during radiotherapy of head-and-neck cancerRadiotherapy and Oncology, 2007
- Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck CancerClinical Cancer Research, 2006
- A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxiaPhysics in Medicine & Biology, 2005
- The impact of daily setup variations on head-and-neck intensity-modulated radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Hypoxia and Glucose Metabolism in Malignant TumorsClinical Cancer Research, 2004
- Hypoxic prostate/muscle po2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findingsUrology, 2002
- Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Keynote address: Cellular reduction of nitroimidazole drugs: Potential for selective chemotherapy and diagnosis of hypoxic cellsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989